{"data":{"id":732,"citation":"Dong Z, Ekins S, Polli JE.: Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Mol Pharm, Volume 10 (3), 2013","title":"Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).","doi":"10.1021\/mp300453k","doi_url":"https:\/\/doi.org\/10.1021\/mp300453k","pmid":"23339484","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23339484\/","year":2013,"journal":"Mol Pharm","volume":"10","issue":"3","page":"1008-1019","authors":[{"first_name":"Dong Z","last_name":null,"full_name":null},{"first_name":"Ekins S","last_name":null,"full_name":null},{"first_name":"Polli JE.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/732","landing_page":"https:\/\/molmedb.upol.cz\/publication\/732","created_at":"2020-08-24T06:50:41.000000Z","updated_at":null}}